36
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of the hypercoagulable state

Whom to screen, how to test and treat

, MD & , MD
Pages 59-66 | Published online: 30 Jun 2015

References

  • Bick RL. Preface. Semin Thromb Hemost 1999; 25(3): 251–3
  • Laffan M, Tuddenham E. Science, medicine, and the future: assessing thrombotic risk. BMJ 1998; 317(7157): 520–3
  • Lensing AW, Prandoni P, Prins MH, et al. Deep-vein thrombosis. Lancet 1999; 353(9151): 479–85
  • Bick RL, Kaplan H. Syndromes of thrombosis and hypercoagulability: congenital and acquired causes of thrombosis. Med Clin North Am 1998; 82(3):409–58
  • Bauer KA, Goodnight SH, Ridker PM. Hypercoagulable states—translation of risk factors to clinical practice. American Society of Hematology education session, Dec 1998; 255–73
  • Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353(9159): 1167–73
  • Bauer KA. The hypercoagulable state: evaluation and management. Update on thrombophilia. American Society of Hematology education session, 1999; 231–5
  • van Cott EM, Laposata M. Laboratory evaluation of hypercoagulable states. Hematol Oncol Clin North Am 1998; 12(6): 1141–66
  • Nachman RL, Silverstein R. Hypercoagulable states. Ann Intern Med 1993; 119(8): 819–27
  • Simioni P, Prandoni P, Lensing AW, et al. The risk of recurrent venous thromboembolism in patients with an Arg 506→Gin mutation in the gene for factor V (factor V Leiden). N Engl J Med 1997; 336(6): 399–403
  • Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 1997; 127(10): 895–903
  • De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999; 341(11):801–6
  • Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000; 342(6): 374–80
  • Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338(15): 1042–50
  • Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332(15): 993–7
  • Prandoni P, Lensing AW, Biiller HR, et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327(16): 1128–33
  • Cornuz J, Pearson SD, Creager MA, et al. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis. Ann Intern Med 1996; 125(10): 785–93
  • Schulman S, Granqvist S, Holmström M, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med 1997; 336(6): 393–8
  • Diuguid DL. Oral anticoagulant therapy for venous thromboembolism. N Engl J Med 1997; 336(6): 433–4
  • Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340(12): 901–7
  • Schafer AI. Venous thrombosis as a chronic disease. N Engl J Med 1999; 340(12): 955–6
  • Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86(10): 3685–91

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.